IPHA has launched a briefing document which sets out how Irish patients are being denied access to new medicines that are readily available in other Western European countries. s.
In a submission made to the National Biosimilar Medicines Policy consultation process, the Irish Pharmaceutical Healthcare Association (IPHA) highlighted the importance of adopting a patient-centric policy on prescribing biologic and biosimilar medicines.
The Irish Pharmaceutical Healthcare Association welcomes the statement by the HSE confirming that it will fund nine delayed medicines for prescribing to patients.
Thousands of patients in Ireland, with serious conditions ranging from heart disease, cancer and skin condition are being denied access to nine new medicines that are routinely available across Europe.
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the new National Cancer Strategy and highlighted the fact that a timely reimbursement system must be in place if it is to deliver on its objectives.
From 1 July next the cost to the State of 780 medicines, most of which are supplied by member companies of the Irish Pharmaceutical Healthcare Association (IPHA), will fall.
World Immunisation Week was marked today at the Royal College of Physicians in Ireland, (RCPI), by Minister for Health, Simon Harris T.D., who launched a new publication, Vaccines for Life, on behalf of the Irish Pharmaceutical Healthcare Association (IPHA).